Clinical Research Directory
Browse clinical research sites, groups, and studies.
Acute Immune Modulation by Probiotic Strain
Sponsor: Natural Immune Systems Inc
Summary
Clinical proof-of-concept study, comparing the acute immune impacts of 3 doses of a probiotic strain to a placebo. This study involves twenty-four participants, composed of healthy adults, who will be taking a placebo and 3 different doses of the probiotic at different times. Testing for immune status and cytokine levels will be conducted to determine the acute impact of the probiotic on immune function when compared to a placebo.
Official title: Acute Immune Modulation by Probiotic Strain Bacillus Coagulans JBI-YZ6.3 (BC4U)
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2024-11-13
Completion Date
2025-12-15
Last Updated
2024-12-31
Healthy Volunteers
Yes
Conditions
Interventions
Probiotic Agent
Bacillus coagulans JBI-YZ6.3 (BC4U)
Probiotic Agent
An escalating dose cross-over design: Participants are fed 0 mg, 100 mg, 200 mg, and 400 mg on different clinic visits.
Locations (1)
NIS Labs
Klamath Falls, Oregon, United States